Achilles Therapeutics plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2024 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q1 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
Achilles Therapeutics plc Earnings Date And Information
Achilles Therapeutics plc last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.41 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Achilles Therapeutics plc has generated $-2 earnings per share over the last year ($-1.74 diluted earnings per share) and currently has a price-to-earnings ratio of -0.64. Achilles Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Achilles Therapeutics plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.48 | $0 | $0 | ||
| 06/28/2024 | Q2 2024 | -$0.41 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.30 | $0 | |||
| 04/04/2024 | Q4 2023 | -$0.47 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.42 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.42 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.44 | $0 | |||
| 03/07/2023 | Q4 2022 | -$0.42 | -$0.61 | -0.19 | $0 | |
| 09/30/2022 | Q3 2022 | -$0.32 | $0 | |||
| 06/30/2022 | Q2 2022 | -$0.44 | $0 | |||
| 03/31/2022 | Q1 2022 | -$0.45 | $0 | |||
| 03/01/2022 | Q4 2021 | -$0.41 | -$0.64 | -0.23 | $0 | |
| 09/30/2021 | Q3 2021 | -$0.34 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.45 | $0 | |||
| 03/31/2021 | Q1 2021 | -$8.38 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.32 | $0 | |||
| 09/30/2020 | Q3 2020 | -$5.00 | $580,000 | |||
| 06/30/2020 | Q2 2020 | -$4.17 | $0 | |||
| 03/31/2020 | Q1 2020 | -$3.18 | $0 | |||
| 01/30/2020 | Q4 2019 | -$6.30 | $0 |
Achilles Therapeutics plc Earnings: Frequently Asked Questions
-
When is Achilles Therapeutics plc's earnings date?
Achilles Therapeutics plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
How can I listen to Achilles Therapeutics plc's earnings conference call?
The conference call for Achilles Therapeutics plc's latest earnings report can be listened to online.
-
How can I read Achilles Therapeutics plc's conference call transcript?
The conference call transcript for Achilles Therapeutics plc's latest earnings report can be read online.
-
How much profit does Achilles Therapeutics plc generate each year?
Achilles Therapeutics plc (:ACHL) has a recorded net income of $0. Achilles Therapeutics plc has generated $-1.74 earnings per share over the last four quarters.
-
What is Achilles Therapeutics plc's price-to-earnings ratio?
Achilles Therapeutics plc (:ACHL) has a price-to-earnings ratio of -0.64 and price/earnings-to-growth ratio is 0.17.
